Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Hemant Surgical Industries's Enterprise Value is ₹5,237 Mil.
Hemant Surgical Industries's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ₹-342 Mil. Therefore, Hemant Surgical Industries's EV-to-FCF for today is -15.33.
The historical rank and industry rank for Hemant Surgical Industries's EV-to-FCF or its related term are showing as below:
BOM:543916'
s EV-to-FCF Range Over the Past 10 Years
Min: -15.45 Med: -9.33 Max: 107.6
Current: -15.33
During the past 6 years, the highest EV-to-FCF of Hemant Surgical Industries was 107.60. The lowest was -15.45. And the median was -9.33.
BOM:543916's EV-to-FCF is ranked worse than 100% of 412
companies
in the Medical Devices & Instruments industry
Industry Median: 24.59
vs BOM:543916: -15.33
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Hemant Surgical Industries's PE Ratio (TTM) for today is calculated as:
Hemant Surgical Industries's share price for today is ₹356.25.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Hemant Surgical Industries's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹14.940.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Hemant Surgical Industries EV-to-FCF Related Terms
Hemant Surgical Industries EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Hemant Surgical Industries's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hemant Surgical Industries EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Hemant Surgical Industries's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Hemant Surgical Industries's EV-to-FCF falls into.
Hemant Surgical Industries's current Enterprise Value is ₹5,237 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Hemant Surgical Industries's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ₹-342 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hemant Surgical Industries (BOM:543916) has a EV-to-FCF of -15.33 as of Aug. 10, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Hemant Surgical Industries and its competitors. According to the industry distribution chart, Hemant Surgical Industries ranks #999999 out of 412 companies in the Medical Devices & Instruments industry.
Is Hemant Surgical Industries' EV-to-FCF too high?
Hemant Surgical Industries' current EV-to-FCF is -15.33. Based on the distribution chart, Hemant Surgical Industries ranks #999999 out of 412 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Hemant Surgical Industries has a GF Score™ of 80/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Hemant Surgical Industries' EV-to-FCF compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Hemant Surgical Industries ranks #999999 out of 412 companies for EV-to-FCF. This places Hemant Surgical Industries in the lower half of its industry. The industry median EV-to-FCF is 24.59. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 24.59, based on 412 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Hemant Surgical Industries and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 24.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hemant Surgical Industries's current EV-to-FCF is -15.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hemant Surgical Industries stock overvalued right now?
Based on GuruFocus' analysis, Hemant Surgical Industries (BOM:543916) is currently considered Fairly Valued. The stock's GF Value™ is ₹335.02, compared to a current price of ₹356.25 — trading 6.3% above its estimated fair value. The current EV-to-FCF is -15.33. Hemant Surgical Industries' overall GF Score™ is 80/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Hemant Surgical Industries (BOM:543916), the current EV-to-FCF is -15.33 as of Aug. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hemant Surgical Industries (BOM:543916) Overvalued in 2026?
Based on GuruFocus' analysis, Hemant Surgical Industries stock appears to be overvalued.
The current stock price of ₹356.25 is trading 6.3% above its estimated GF Value™ of ₹335.02.
GuruFocus considers Hemant Surgical Industries to be Fairly Valued.
Key valuation signals for BOM:543916:
EV-to-FCF: -15.33
GF Value™: ₹335.02 vs. price of ₹356.25 (6.3% above fair value)
No single metric tells the full story. See the BOM:543916 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hemant Surgical Industries Ltd is engaged in Importing, manufacturing, and marketing quality surgical and Pharmaceutical Products at an economical price. Its product offerings cover a wide spectrum of equipment and disposables required for (i) Renal Care, (ii) Cardiovascular Disease, (iii) Respiratory Disease, (iv) Critical Care and Radiology, and (v) Surgical disposables. Its products include JMS Meditape, JMS Infusion Set, JMS Scalp Vein Set, Ventilators, ECG Machines, and others.
80GF Score
Get the complete analysis for BOM:543916
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543916 has been successfully added to your 
